Your browser doesn't support javascript.
loading
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Yang, Xin; Leslie, Goska; Doroszuk, Alicja; Schneider, Sandra; Allen, Jamie; Decker, Brennan; Dunning, Alison M; Redman, James; Scarth, James; Plaskocinska, Inga; Luccarini, Craig; Shah, Mitul; Pooley, Karen; Dorling, Leila; Lee, Andrew; Adank, Muriel A; Adlard, Julian; Aittomäki, Kristiina; Andrulis, Irene L; Ang, Peter; Barwell, Julian; Bernstein, Jonine L; Bobolis, Kristie; Borg, Åke; Blomqvist, Carl; Claes, Kathleen B M; Concannon, Patrick; Cuggia, Adeline; Culver, Julie O; Damiola, Francesca; de Pauw, Antoine; Diez, Orland; Dolinsky, Jill S; Domchek, Susan M; Engel, Christoph; Evans, D Gareth; Fostira, Florentia; Garber, Judy; Golmard, Lisa; Goode, Ellen L; Gruber, Stephen B; Hahnen, Eric; Hake, Christopher; Heikkinen, Tuomas; Hurley, Judith E; Janavicius, Ramunas; Kleibl, Zdenek; Kleiblova, Petra; Konstantopoulou, Irene; Kvist, Anders.
Afiliação
  • Yang X; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Doroszuk A; Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Schneider S; Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Allen J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Decker B; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Dunning AM; Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
  • Redman J; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Scarth J; Centre for Cancer Genetic Epidemiology, Department of Oncology,University of Cambridge, Cambridge, United Kingdom.
  • Plaskocinska I; Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Luccarini C; Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Shah M; Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom.
  • Pooley K; Centre for Cancer Genetic Epidemiology, Department of Oncology,University of Cambridge, Cambridge, United Kingdom.
  • Dorling L; Centre for Cancer Genetic Epidemiology, Department of Oncology,University of Cambridge, Cambridge, United Kingdom.
  • Lee A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Adank MA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Adlard J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Aittomäki K; Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Andrulis IL; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.
  • Ang P; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Barwell J; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Bernstein JL; Laboratory of Molecular Oncology, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Bobolis K; Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
  • Borg Å; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Blomqvist C; Clinical Cancer Genomics Community Research Network, City of Hope, Duarte, CA.
  • Claes KBM; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Concannon P; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Cuggia A; Centre for Medical Genetics, Ghent University, Ghent, Belgium.
  • Culver JO; University of Florida Genetics Institute, University of Florida, Gainesville, FL.
  • Damiola F; The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • de Pauw A; The Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.
  • Diez O; Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.
  • Dolinsky JS; Biopathologie, Centre Léon Bérard, Lyon, France.
  • Domchek SM; Service de Génétique, Institut Curie, Paris, France.
  • Engel C; Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Vall d'Hebron, Barcelona, Spain.
  • Evans DG; Ambry Genetics, Aliso Viejo, CA.
  • Fostira F; Department ofMedicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Garber J; Prospective Registry of Multiplex Testing (PROMPT), United States and Europe.
  • Golmard L; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Goode EL; Division of Evolution and Genomic Sciences, University of Manchester; Manchester Centre for Genomic Medicine, St Mary's Hospital-Manchester University Hospitals NHS Foundation Trust; and Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Gruber SB; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos," Athens, Greece.
  • Hahnen E; Prospective Registry of Multiplex Testing (PROMPT), United States and Europe.
  • Hake C; Dana-Farber Cancer Institute, Boston, MA.
  • Heikkinen T; Service de Génétique, Institut Curie, Paris, France.
  • Hurley JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Janavicius R; City of Hope National Medical Center, Duarte, CA.
  • Kleibl Z; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Kleiblova P; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
  • Konstantopoulou I; Clinical Cancer Genomics Community Research Network, City of Hope, Duarte, CA.
  • Kvist A; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
J Clin Oncol ; 38(7): 674-685, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31841383
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteína do Grupo de Complementação N da Anemia de Fanconi / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteína do Grupo de Complementação N da Anemia de Fanconi / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido